SEC Form 4 · accession 0001140361-16-072821
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Willard H Dere
Director
Period of report
Jul 15, 2016
Accepted (ET)
Jul 19, 2016 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 15, 2016 | A | 3,300 | $0.00 | A | 3,300 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy Common Stock)F2 | $92.08 | Jul 15, 2016 | A | 8,230 | A | Jul 15, 2017 | Jul 14, 2026 | Common Stock | 8,230 | 8,230 | D |
Explanation of responses
- F1Restricted stock units granted on July 15, 2016 vest annually over three years. Price not applicable.
- F2Original option grant vests annually over three years